A detailed history of Israel Englander (Millennium Management LLC) transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Millennium Management LLC holds 130,070 shares of SCPH stock, worth $564,503. This represents 0.0% of its overall portfolio holdings.

Number of Shares
130,070
Previous 189,084 31.21%
Holding current value
$564,503
Previous $949,000 40.46%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$3.51 - $5.21 $207,139 - $307,462
-59,014 Reduced 31.21%
130,070 $565,000
Q1 2024

May 15, 2024

SELL
$4.86 - $6.39 $815,454 - $1.07 Million
-167,789 Reduced 47.02%
189,084 $949,000
Q4 2023

Feb 14, 2024

SELL
$4.7 - $6.63 $4.04 Million - $5.7 Million
-859,333 Reduced 70.66%
356,873 $2.24 Million
Q2 2023

Aug 14, 2023

SELL
$8.94 - $11.74 $3.91 Million - $5.14 Million
-437,807 Reduced 26.47%
1,216,206 $12.4 Million
Q1 2023

May 15, 2023

BUY
$5.59 - $9.47 $4.63 Million - $7.84 Million
828,288 Added 100.31%
1,654,013 $15 Million
Q4 2022

Feb 14, 2023

BUY
$4.02 - $7.53 $3.22 Million - $6.03 Million
800,408 Added 3161.54%
825,725 $5.92 Million
Q3 2022

Nov 14, 2022

SELL
$4.48 - $6.52 $48,827 - $71,061
-10,899 Reduced 30.09%
25,317 $165,000
Q2 2022

Aug 15, 2022

BUY
$4.3 - $6.48 $49,213 - $74,163
11,445 Added 46.2%
36,216 $175,000
Q1 2022

May 16, 2022

SELL
$3.9 - $6.11 $33,411 - $52,344
-8,567 Reduced 25.7%
24,771 $141,000
Q4 2021

Feb 14, 2022

SELL
$3.88 - $6.9 $791 - $1,407
-204 Reduced 0.61%
33,338 $167,000
Q3 2021

Nov 15, 2021

SELL
$4.93 - $7.15 $119,182 - $172,851
-24,175 Reduced 41.89%
33,542 $223,000
Q2 2021

Aug 16, 2021

BUY
$5.19 - $7.38 $299,551 - $425,951
57,717 New
57,717 $353,000
Q2 2020

Aug 14, 2020

SELL
$7.01 - $10.96 $245,763 - $384,246
-35,059 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$5.4 - $10.45 $189,318 - $366,366
35,059 New
35,059 $259,000
Q3 2019

Nov 14, 2019

SELL
$3.24 - $7.35 $109,447 - $248,283
-33,780 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$2.48 - $3.76 $83,774 - $127,012
33,780 New
33,780 $108,000
Q3 2018

Nov 14, 2018

SELL
$4.22 - $6.03 $81,446 - $116,379
-19,300 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$5.53 - $15.4 $106,729 - $297,220
19,300 New
19,300 $109,000
Q1 2018

May 15, 2018

SELL
$11.62 - $17.32 $443,674 - $661,312
-38,182 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$11.8 - $17.31 $450,547 - $660,930
38,182
38,182 $462,000

Others Institutions Holding SCPH

About scPharmaceuticals Inc.


  • Ticker SCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,402,100
  • Market Cap $119M
  • Description
  • scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...
More about SCPH
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.